Yu Wang is a Principal Scientist at Biogen, where since May 2016, the focus has been on leading groups in biologics, biosimilars, and gene therapy analytical development. Previously, Yu Wang held the title of Senior Scientist and Scientist II at Biogen, specializing in analytical development for gene therapy programs, including bioanalytical data handling and the implementation of new analytical technologies. Prior to Biogen, Yu Wang worked as a Research Fellow at Boston Children's Hospital, investigating epigenetics and cancer drug resistance using advanced techniques like CRISPR and high-throughput sequencing. Early career experiences include a Research Associate position at UNC-Chapel Hill and a Graduate Student role at Mayo Clinic, where cancer cell biology was a primary area of research. Yu Wang earned a Ph.D. in Cell Biology and Genetics from Mayo Clinic College of Medicine and Science and a B.S. in Life Sciences from Fudan University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices